Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA452459
Max Phase: Preclinical
Molecular Formula: C12H24N2O4
Molecular Weight: 260.33
Molecule Type: Small molecule
Associated Items:
ID: ALA452459
Max Phase: Preclinical
Molecular Formula: C12H24N2O4
Molecular Weight: 260.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO
Standard InChI: InChI=1S/C12H24N2O4/c1-4-6-13-9(16)5-7-14-11(18)10(17)12(2,3)8-15/h10,15,17H,4-8H2,1-3H3,(H,13,16)(H,14,18)/t10-/m0/s1
Standard InChI Key: QACSALMWBOZZLM-JTQLQIEISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 260.33 | Molecular Weight (Monoisotopic): 260.1736 | AlogP: -0.60 | #Rotatable Bonds: 8 |
Polar Surface Area: 98.66 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.69 | CX Basic pKa: | CX LogP: -1.06 | CX LogD: -1.06 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.47 | Np Likeness Score: -0.26 |
1. Mercer AC, Meier JL, Hur GH, Smith AR, Burkart MD.. (2008) Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli., 18 (22): [PMID:18701278] [10.1016/j.bmcl.2008.07.078] |
2. PubChem BioAssay data set, |
3. de Villiers M, Macuamule C, Spry C, Hyun YM, Strauss E, Saliba KJ.. (2013) Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity., 4 (8): [PMID:24900746] [10.1021/ml400180d] |
Source(2):